Reports
Sale
Latin America Tumor Ablation Market Size, Share, Trends: By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Ablation Technologies; By Application: Kidney Cancer, Liver Cancer, Others; By Mode of Treatment; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Latin America Tumor Ablation Market Outlook
The global tumor ablation market size was valued at USD 1.9 billion in 2023, with Latin America holding a significant market share. The market is driven by the rising introduction of advanced technologies in tumor ablation. It is expected to grow at a CAGR of 14.2% during the forecast period of 2024-2032, with the values likely to attain USD 6.3 billion by 2032.
Key Takeaways
- Recent data reveals that 9 in 10 of the most populous nations in Latin America will observe at least a 64% increase in cancer patients by 2040 . The high cancer incidence is expected to directly impact market demand for this minimally invasive technique.
- One of the major Latin America tumor ablation market trends is the increased initiatives by both public and private organizations to spread awareness about cancer treatment strategies. In October 2023, the Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) announced the first edition of Latin America and the Caribbean Code Against Cancer with the objective of reducing cancer cases in the region.
- The market is also influenced by the minimally invasive nature of tumor ablation therapy which fuels its adoption rate due to shorter recovery times and fewer complications compared to traditional surgeries to treat cancer.
Latin America Tumor Ablation Market Analysis
Tumor ablation is a medical procedure that is utilized to destroy cancer cells in a tumor in various parts of the body, such as the liver, kidney, and bone. Some common tumor ablation approaches include radiofrequency ablation (RFA) and cryoablation. This technique can help in localized destruction of cancerous cells without the need for invasive surgery. Due to its minimally invasive nature, this technique is associated with shorter recovery times and fewer complications than traditional surgeries. Hence, the Latin America tumor ablation market demand is expected to witness a surge in the coming years.
Latin America has a significant burden of cancer which can be attributed to the rising aging populations, lifestyle changes, and genetic factors. Recent data reveals that 9 in 10 of the most populous nations in Latin America will observe at least a 64% increase in cancer patients by 2040. Further, it is estimated that nearly 1 million new cancer cases will occur in Brazil each year, which indicates the urgent need for effective cancer treatment options including tumor ablation techniques for managing different types of cancer. Consequently, the high cancer incidence is expected to drive the Latin America tumor ablation market growth.
The market is also influenced by the increased initiatives by both public and private organizations to tackle the growing cancer burden and spread awareness about its management strategies including advanced procedures like tumor ablation. For instance, in October 2023, the Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) announced the first edition of Latin America and the Caribbean Code Against Cancer with the objective of reducing cancer cases in the region. As a part of the World Code Against Cancer, the new Code will offer latest recommendations based on the most recent scientific evidence, influencing changes in health policies and behaviors to prevent cancer. Such initiatives are likely to heighten public awareness regarding the benefits of tumor ablation therapy and enhance its adoption rate, which is poised to augment the market share.
Latin America Tumor Ablation Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Technology | Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Ablation Technologies |
| Application | Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Bone Cancer |
| Mode of Treatment | Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation |
| End User | Hospitals, Cancer Specialty Clinics, Others |
| Country | Brazil, Argentina, Mexico, Others |
Latin America Tumor Ablation Market: Competitor Landscape
The key features of the market report include funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Medtronic
- Boston Scientific Corporation
- AngioDynamics
- Mermaid Medical
- HealthTronics
- Galil Medical Inc.
- EDAP TMS S.A.
- Misonix, Inc.
- NeuWave Medical, Inc.
- SonaCare Medical
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by Mode of Treatment |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Latin America Tumor Ablation Market Overview
3.1 Latin America Tumor Ablation Market Historical Value (2017-2023)
3.2 Latin America Tumor Ablation Market Forecast Value (2024-2032)
4 Latin America Tumor Ablation Market Landscape*
4.1 Latin America Tumor Ablation: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Latin America Tumor Ablation: Product Landscape
4.2.1 Analysis by Technology
4.2.2 Analysis by Application
5 Latin America Tumor Ablation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Latin America Tumor Ablation Market Segmentation (2017-2032)
6.1 Latin America Tumor Ablation Market (2017-2032) by Technology
6.1.1 Market Overview
6.1.2 Radiofrequency Ablation
6.1.3 Microwave Ablation
6.1.4 Cryoablation
6.1.5 Irreversible Electroporation Ablation
6.1.6 Other Ablation Technologies
6.2 Latin America Tumor Ablation Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Kidney Cancer
6.2.3 Liver Cancer
6.2.4 Breast Cancer
6.2.5 Lung Cancer
6.2.6 Prostate Cancer
6.2.7 Bone Cancer
6.3 Latin America Tumor Ablation Market (2017-2032) by Mode of Treatment
6.3.1 Market Overview
6.3.2 Surgical Ablation
6.3.3 Laparoscopic Ablation
6.3.4 Percutaneous Ablation
6.4 Latin America Tumor Ablation Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Cancer Specialty Clinics
6.4.4 Others
6.5 Latin America Tumor Ablation Market (2017-2032) by Country
6.5.1 Market Overview
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Others
7 Brazil Tumor Ablation Market (2017-2032)
7.1 Brazil Tumor Ablation Market (2017-2032) by Technology
7.1.1 Market Overview
7.1.2 Radiofrequency Ablation
7.1.3 Microwave Ablation
7.1.4 Cryoablation
7.1.5 Irreversible Electroporation Ablation
7.1.6 Other Ablation Technologies
7.2 Brazil Tumor Ablation Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Kidney Cancer
7.2.3 Liver Cancer
7.2.4 Breast Cancer
7.2.5 Lung Cancer
7.2.6 Prostate Cancer
7.2.7 Bone Cancer
7.3 Brazil Tumor Ablation Market (2017-2032) by Mode of Treatment
7.3.1 Market Overview
7.3.2 Surgical Ablation
7.3.3 Laparoscopic Ablation
7.3.4 Percutaneous Ablation
7.4 Brazil Tumor Ablation Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Hospitals
7.4.3 Cancer Specialty Clinics
7.4.4 Others
8 Argentina Tumor Ablation Market (2017-2032)
8.1 Argentina Tumor Ablation Market (2017-2032) by Technology
8.1.1 Market Overview
8.1.2 Radiofrequency Ablation
8.1.3 Microwave Ablation
8.1.4 Cryoablation
8.1.5 Irreversible Electroporation Ablation
8.1.6 Other Ablation Technologies
8.2 Argentina Tumor Ablation Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Kidney Cancer
8.2.3 Liver Cancer
8.2.4 Breast Cancer
8.2.5 Lung Cancer
8.2.6 Prostate Cancer
8.2.7 Bone Cancer
8.3 Argentina Tumor Ablation Market (2017-2032) by Mode of Treatment
8.3.1 Market Overview
8.3.2 Surgical Ablation
8.3.3 Laparoscopic Ablation
8.3.4 Percutaneous Ablation
8.4 Argentina Tumor Ablation Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Hospitals
8.4.3 Cancer Specialty Clinics
8.4.4 Others
9 Mexico Tumor Ablation Market (2017-2032)
9.1 Mexico Tumor Ablation Market (2017-2032) by Technology
9.1.1 Market Overview
9.1.2 Radiofrequency Ablation
9.1.3 Microwave Ablation
9.1.4 Cryoablation
9.1.5 Irreversible Electroporation Ablation
9.1.6 Other Ablation Technologies
9.2 Mexico Tumor Ablation Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Kidney Cancer
9.2.3 Liver Cancer
9.2.4 Breast Cancer
9.2.5 Lung Cancer
9.2.6 Prostate Cancer
9.2.7 Bone Cancer
9.3 Mexico Tumor Ablation Market (2017-2032) by Mode of Treatment
9.3.1 Market Overview
9.3.2 Surgical Ablation
9.3.3 Laparoscopic Ablation
9.3.4 Percutaneous Ablation
9.4 Mexico Tumor Ablation Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Hospitals
9.4.3 Cancer Specialty Clinics
9.4.4 Others
10 Regulatory Framework
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 Medtronic
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 Boston Scientific Corporation
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 Angiodynamics
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Mermaid Medical
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 HealthTronics
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Galil Medical Inc.
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 EDAP TMS S.A.
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 Misonix, Inc.
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Neuwave Medical, Inc.
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
13.11 SonaCare Medical
13.11.1 Financial Analysis
13.11.2 Product Portfolio
13.11.3 Demographic Reach and Achievements
13.11.4 Mergers and Acquisitions
13.11.5 Certifications
14 Latin America Tumor Ablation Market – Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The Latin America tumor ablation market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 14.2% during the forecast period of 2024-2032 and is likely to reach a market value of USD 6.3 billion by 2032.
The rising demand for minimally invasive techniques to treat cancer is fuelling the demand for the market.
One of the significant trends in the market is the increased initiatives by both public and private organizations to spread awareness about cancer treatment strategies. In October 2023, the Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) announced the first edition of Latin America and the Caribbean Code Against Cancer with the objective of reducing cancer cases in the region.
Based on the type, the market is segmented into adenoviral vectors, adeno-associated viral (AAV) vectors, lentiviral vectors, and retroviral vectors, among others.
By therapeutic area, the market is divided into oncological disorders, neurological disorders, metabolic disorders, and immunological disorders, among others.
End users of the market are research organizations, biotech, and pharmaceutical companies, among others.
Major applications of tumor ablation include gene therapy, cell therapy, and vaccines.
The market segmentation by countries includes Brazil, Argentina, and Mexico, among others.
The key players in the market are Medtronic, Boston Scientific Corporation, Angiodynamics, Mermaid Medical, HealthTronics, Galil Medical Inc., EDAP TMS S.A., Misonix, Inc., NeuWave Medical, Inc., and SonaCare Medical.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER